Fasciola hepatica extract suppresses fibroblast-like synoviocytes in vitro and alleviates experimental arthritis.

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation, fibroblast-like synoviocytes (FLS) activation and joint destruction. Fasciola hepatica is a platyhelminth that releases excretory-secretory immunomodulatory products capable of suppressing the Th1 immune response. Despite the effectiveness of available treatments for inducing disease remission, current options are not successful in all patients and may cause side effects. Thus, we evaluated the therapeutic potential of F. hepatica extract on FLS from RA patients and arthritis models. METHODS: FLS were isolated from synovial fluid of RA patients, cultured, and exposed to F. hepatica extract (60, 80, and 100 µg/ml) for different time points to assess cell viability, adherence, migration and invasion. For in vivo experiments, mice with antigen (AIA) and collagen (CIA) induced arthritis received a 200 µg/dose of F. hepatica extract daily. Statistical analysis was performed by ANOVA and Student's t-test using GraphPad Prism 6.0. RESULTS: In vitro assays showed that extract decreased FLS cell viability at concentration of 100 µg/ml (83.8% ± 5.0 extract vs. 100.0% ± 0.0 control; p < 0.05), adherence in 20% (92.0 cells ± 5.8 extract vs. 116.3 cells ± 7.9 control; p < 0.05), migratory potential (69.5% ± 17.6 extract vs. 100.0% control; p < 0.05), and cell invasiveness potential through the matrigel (76.0% ± 8.4 extract vs. 100.0% control; p < 0.01). The extract reduced leukocyte migration by 56% (40 × 104 leukocytes/knee ± 19.00) compared to control (90.90 × 104 leukocytes/knee ± 12.90) (p < 0.01) and nociception (6.37 g ± 0.99 extract vs. 3.81 g ± 1.44 control; p < 0.001) in AIA and delayed clinical onset of CIA (11.75 ± 2.96 extract vs. 14.00 ± 2.56 control; p = 0.126). CONCLUSION: Our results point out a potential immunomodulatory effect of F. hepatica extract in RA models. Therefore, the characterization of promising new immunomodulatory molecules should be pursued, as they can promote the development of new therapies. Trial registration Collection of synovial liquid and in vitro procedures were approved by the Ethics Committee with Certificate of Presentation of Ethical Appreciation in Plataforma Brasil (CAAE: 89044918.8.0000.5327; date of registration: 26/07/2018).

Evaluation of EDTA and nitric acid solutions for decalcification of joints in AG/WT, BALB/c, C57, DBA1/J mice, and in Wistar rats.

Decalcification of mineralized samples for microscopic analysis involves competing factors including decalcification time, preservation of tissue integrity and cost. We investigated the utility of different decalcification solutions for studying joints in AG/WT, BALB/c, C57, DBA1/J mice and Wistar rats. The hind paws of the rodents were removed and fixed with 10% buffered formalin. Specimens were divided randomly into three groups for demineralization: 10% nitric acid, 12.5% EDTA at room temperature and 12.5% EDTA at 35 °C with shaking. Sections of joints were stained with hematoxylin and eosin (H & E). We evaluated decalcification time and expense, ease of cutting sections, preservation of nuclear basophilia and intranuclear detail, and intensity of eosin staining. The 10% nitric acid solution produced the most rapid decalcification for the mice, but not the rats. The 12.5% EDTA solution at 35 °C with shaking did not decrease decalcification time. Effects on microtomy were variable as were the effects on H & E staining. The EDTA solution provided the best basophilia and intranuclear detail for the mice. For rats, only 12.5% EDTA at 35 °C with shaking produced good preservation. Preservation of nuclear basophilia and intranuclear detail for rats was best with 10% nitric acid and EDTA 35 °C. For mice, 10% nitric acid failed to preserve nuclear basophilia and intranuclear detail. For intensity of eosin staining, EDTA at room temperature and EDTA 35 °C was best for both mice and rats. Sections also exhibited good H & E staining in most samples decalcified with 10% nitric acid. Although we found considerable variation among groups of animals, we found less variation among the different mouse strains than between mice and Wistar rats.

Ototoxicity of an association of insecticides compounds containing dichlorvos and cypermethrin in Wistar rats

ABSTRACT Purpose: to evaluate possible ototoxicity secondary to exposure to a combination of pesticides (dichlorvos and cypermethrin based insecticides). Methods: the Wistar rats were divided into 3 groups (12 animals per group): control (water), positive control for hearing damage (cisplatin) and experimental (exposed to dichlorvos and cypermethrin). The amplitude of distortion product otoacoustic emissions was assessed before and after the exposure. Systemic toxicity signs were also evaluated (clinical signs, weight gain and plasma cholinesterase). Wilcoxon test analyzed the post-exposure amplitudes compared to pre-exposure and Kruskal Wallis following Dunn's post hoc tests analyzed the amplitudes' variation. Normally distributed variables were evaluated by Student's t test. Results: body weight and plasma cholinesterase values were similar comparing the pre and post exposure in the experimental group. The control group did not manifest significant amplitude reduction of otoacoustic emissions between the pre and post evaluation. In the group exposed to cisplatin there was a significant reduction in amplitudes at 12 kHz on the right (p = 0.006; Wilcoxon) and 4 kHz on the left (p = 0.032; Wilcoxon). In the group exposed to pesticides, there was a significant reduction in the right ear at 4 kHz (p = 0.034; Wilcoxon) and 8 kHz (p = 0.019; Wilcoxon) and in the left ear at 4 kHz (p = 0.007; Wilcoxon), 6 kHz (p = 0.023; Wilcoxon), 8 kHz (p = 0.045; Wilcoxon) and 12 kHz (p = 0.028; Wilcoxon). Conclusion: there was ototoxicity in the experimental group, without a relevant systemic toxicity.

Modelos animais para avaliação auditiva: revisão de literatura / Animal models for hearing evaluations: a literature review

RESUMO O objetivo dessa revisão é delinear os modelos animais viáveis para a pesquisa pré-clínica auditiva, considerando suas características anatômicas, fisiológicas, vantagens e desvantagens. Foram consultadas as bases de dados Scielo, Pubmed e Periódicos Capes, utilizando descritores envolvendo audição, testes auditivos e espécies animais, individualmente e cruzados entre si. Foram lidos os resumos dos artigos encontrados nas bases de dados, com posterior seleção baseada nos critérios: artigos disponíveis em sua integridade, uso de modelos animais em procedimentos audiológicos que incluísse a descrição dos métodos de avaliação, as vantagens e/ou desvantagens do uso da espécie, publicados entre 1995 e 2016. Apesar da existência de modelos alternativos, os mamíferos são ainda amplamente utilizados em pesquisa. Constatou-se que os ratos, camundongos e cobaios são frequentemente utilizados e, além destes, ovelhas, coelhos e chinchilas. Os métodos para avaliação auditiva contemplam principalmente emissões otoacústicas por produto de distorção, potencial evocado auditivo de tronco encefálico e avaliação histológica, principalmente em roedores. A escolha do animal de experimentação para avaliação do sistema auditivo depende de fatores anatômicos, fisiológicos, econômicos, espaciais, psicossociais e do objetivo da avaliação.

ABSTRACT This review aims to outline which animal models are viable for preclinical hearing research, considering their anatomical and physiological characteristics, and their advantages and disadvantages of use. PubMed, Scielo, and Portal Periodicos Capes were consulted, using descriptors concerning hearing, hearing tests and animal species, individually and crossed with each other. The abstracts of the articles found in the databases were read, with subsequent selection based on the following criteria: free articles, use of animal models in audiological procedures that included the description of the evaluation methods, the advantages and/or disadvantages of using the species, and published between 1995 and 2016. Despite the existence of alternative models, mammals are still widely used in research. It has been found that rats, mice and guinea pigs are frequently used, and, in addition to these, sheep, rabbits and chinchillas. The methods for auditory evaluation mainly comprise distortion product otoacoustic emissions, brainstem auditory evoked potential and histological evaluation, especially in rodents. Choosing the experimental animal to evaluate the auditory system depends on anatomical, physiological, economic, spatial and psychosocial factors, and on the evaluation's objective.